Advertisement

Topics

SurModics, Inc. Company Profile

00:26 EDT 25th September 2017 | BioPortfolio

SurModics’ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the world’s foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its SurModics Pharmaceuticals subsidiary is located in Birmingham, Alabama. For more information about the Company, visit www.surmodics.com. The content of SurModics’ website is not part of this release or part of any filings the Company makes with the SEC.


News Articles [18 Associated News Articles listed on BioPortfolio]

Surmodics's next-gen drug-coated balloon gets IDE from FDA

Surmodics has obtained an investigational device exemption from the FDA to conduct a pivotal clinical trial of its SurVeil dr -More- 

FDA, EU clear SurModics' low-profile PTA balloon dilation catheter

The FDA gave SurModics 510(k) clearance for its 0.014-inch low-profile percutaneous transluminal angioplasty balloon dilation -More- 

Surmodics secures IDE approval to start trial of SurVeil drug-coated balloon

Surmodics has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal clinical trial of the SurVeil™ drug-coated balloon (DCB).

Surmodics to Present at Upcoming Investor Conferences

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that Gary Maharaj, president ...

SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 01052017] Prices from USD $350

SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inc...

SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 12062017] Prices from USD $350

SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's SurModics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report inc...

Surmodics to Webcast Third Quarter 2017 Earnings Conference Call on August 3

Webcast is Live at 7:30 a.m. (CT) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today ...

Surmodics' (SRDX) CEO Gary Maharaj on Q3 2017 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon

PREVEIL is a prospective, multi-center, single-arm clinical trial to assess the safety and functionality of the SurModics drug coated balloon (DCB) in the treatment of subjects with sympto...

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral an...

Companies [3 Associated Companies listed on BioPortfolio]

SurModics, Inc.

SurModics’ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the world’s foremost medical device, pharmaceut...

Bringing Innovation Together

SurModics is a leading provider of surface modification and drug delivery solutions for the health care industry. One of SurModics’ core technology platforms is its patented drug-delivery polymer ma...

SurModics

Our Mission To enhance the well-being of our clients and their customers by providing the world's foremost innovative surface-modification technologies and related products. Our Guiding Principles ...

More Information about "SurModics, Inc." on BioPortfolio

We have published hundreds of SurModics, Inc. news stories on BioPortfolio along with dozens of SurModics, Inc. Clinical Trials and PubMed Articles about SurModics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SurModics, Inc. Companies in our database. You can also find out about relevant SurModics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record